Pay in 4 interest-free payments of $6.33 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Your first payment processes immediately and your order ships normally
the control group had inhaled short-acting beta-2 agonist use (32.3% vs
Timing varies by individual and program structure
Quanta Pharma Retatrutide 50mg Specifications Retatrutide 50mg by Quanta Pharma Quanta Pharma Retatrutide Research Benefits Triple receptor action - Targets GLP-1, GIP, and Glucagon receptors for the most comprehensive metabolic research available Superior weight management - Clinical trials showed greater weight reduction compared to dual agonists like Tirzepatide Enhanced fat oxidation - Glucagon receptor activation promotes direct fat burning and energy expenditure Glycemic control - Researched for improving insulin sensitivity and glucose metabolism Extended half-life - Approximately 6 days allows for once-weekly administration in research protocols How Quanta Pharma Retatrutide Works Quanta Pharma Retatrutide is a triple agonist peptide that simultaneously activates three key receptors involved in metabolic regulation: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and the Glucagon receptor
US$ 28.63
US$ 26.13
US$ 25.48
